View Archive »
About The Cover
The cover for issue 27 of Oncotarget features Figure 5, "MYC overexpression in DAOY (YM21) does not alter PD-L1 expression," from Martin, et al.
|
|
Table of Contents
Research Papers: Immunology
|
| Tumor cell death after electrotransfer of plasmid DNA is associated with cytosolic DNA sensor upregulation |
|
https://doi.org/10.18632/oncotarget.24816
|
| 18665-18681 |
Research Papers
|
| Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice |
|
https://doi.org/10.18632/oncotarget.24588
|
| 18682-18697 |
|
| Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer |
|
https://doi.org/10.18632/oncotarget.24617
|
| 18698-18711 |
|
| Comprehensive analysis of telomerase inhibition by gallotannin |
|
https://doi.org/10.18632/oncotarget.24642
|
| 18712-18719 |
|
| Protumoral immune cell alterations in wild type and Shbdeficient mice in response to 4T1 breast carcinomas |
|
https://doi.org/10.18632/oncotarget.24643
|
| 18720-18733 |
|
| BET inhibition is an effective approach against KRASdriven PDAC and NSCLC |
|
https://doi.org/10.18632/oncotarget.24648
|
| 18734-18746 |
|
| Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma in vitro |
|
https://doi.org/10.18632/oncotarget.24650
|
| 18747-18759 |
|
| Synapsin I and Synapsin II regulate neurogenesis in the dentate gyrus of adult mice |
|
https://doi.org/10.18632/oncotarget.24655
|
| 18760-18774 |
|
| Integrated multigene expression panel to prognosticate patients with gastric cancer |
|
https://doi.org/10.18632/oncotarget.24661
|
| 18775-18785 |
|
| Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancerspecific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy |
|
https://doi.org/10.18632/oncotarget.24666
|
| 18786-18796 |
|
| Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma A population based analysis |
|
https://doi.org/10.18632/oncotarget.24694
|
| 18797-18810 |
|
| A phase II trial of 1stline modifiedFOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC11 |
|
https://doi.org/10.18632/oncotarget.24702
|
| 18811-18820 |
|
| Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10 |
|
https://doi.org/10.18632/oncotarget.24568
|
| 18821-18831 |
|
| Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system |
|
https://doi.org/10.18632/oncotarget.24777
|
| 18832-18843 |
|
| Isolated metastasis of an EGFRL858Rmutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis followup and treatment |
|
https://doi.org/10.18632/oncotarget.24787
|
| 18844-18857 |
|
| Glycine: a noninvasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours |
|
https://doi.org/10.18632/oncotarget.24789
|
| 18858-18868 |
|
| Recruitment of mitofusin 2 into “lipid rafts†drives mitochondria fusion induced by Mdivi1 |
|
https://doi.org/10.18632/oncotarget.24792
|
| 18869-18884 |
|
| Differentiationinducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET |
|
https://doi.org/10.18632/oncotarget.24421
|
| 18885-18895 |
|
| DNMT1 ablation suppresses tumorigenesis by inhibiting the selfrenewal of esophageal cancer stem cells |
|
https://doi.org/10.18632/oncotarget.24116
|
| 18896-18907 |
|
| Assessment of the Palliative Prognostic Index in hospitalized oncologic patients treated by a palliative care team: impact of acute concomitant diseases |
|
https://doi.org/10.18632/oncotarget.24826
|
| 18908-18915 |
|
| Loss of nuclear NOTCH1 but not its negative regulator NUMB is an independent predictor of cervical malignancy |
|
https://doi.org/10.18632/oncotarget.24828
|
| 18916-18928 |
|
| Salivary microRNAs as new molecular markers in cleft lip and palate: a new frontier in molecular medicine |
|
https://doi.org/10.18632/oncotarget.24838
|
| 18929-18938 |
|
| Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease |
|
https://doi.org/10.18632/oncotarget.24851
|
| 18939-18948 |
|
| The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2deoxyglucose inhibition |
|
https://doi.org/10.18632/oncotarget.24855
|
| 18949-18969 |
|
| Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.24863
|
| 18970-18984 |
|
| A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer |
|
https://doi.org/10.18632/oncotarget.24867
|
| 18985-18996 |
|
| Extracellular nicotinamide phosphoribosyltransferase eNAMPT is a novel marker for patients with BRAFmutated metastatic melanoma |
|
https://doi.org/10.18632/oncotarget.24871
|
| 18997-19005 |
|
| Glypican1 is enriched in circulatingexosomes in pancreatic cancer and correlates with tumor burden |
|
https://doi.org/10.18632/oncotarget.24873
|
| 19006-19013 |
|
| miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children |
|
https://doi.org/10.18632/oncotarget.24874
|
| 19014-19025 |
|
| Near infrared photoimmunotherapy targeting bladder cancer with a canine antiepidermal growth factor receptor EGFR antibody |
|
https://doi.org/10.18632/oncotarget.24876
|
| 19026-19038 |
|
| Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes |
|
https://doi.org/10.18632/oncotarget.24886
|
| 19039-19049 |
|
| Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer |
|
https://doi.org/10.18632/oncotarget.24887
|
| 19050-19064 |
|
| Correlation between lower balance of Th2 helper Tcells and expression of PDL1/PD1 axis genes enables prognostic prediction in patients with glioblastoma |
|
https://doi.org/10.18632/oncotarget.24897
|
| 19065-19078 |
|
| An epigenetic regulatorrelated score EpiScore predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy |
|
https://doi.org/10.18632/oncotarget.24901
|
| 19079-19099 |
|
| Myofibroblast androgen receptor expression determines cell survival in cocultures of myofibroblasts and prostate cancer cells in vitro |
|
https://doi.org/10.18632/oncotarget.24913
|
| 19100-19114 |
|
| Total lesion glycolysis on FDGPET/CT before salvage surgery predicts survival in laryngeal or pharyngeal cancer |
|
https://doi.org/10.18632/oncotarget.24914
|
| 19115-19122 |
|
| Hypoxiainducible factor2 alpha upregulates CD70 under hypoxia and enhances anchorageindependent growth and aggressiveness in cancer cells |
|
https://doi.org/10.18632/oncotarget.24919
|
| 19123-19135 |
|
| Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease |
|
https://doi.org/10.18632/oncotarget.24927
|
| 19136-19146 |
|
| CD200fc enhances antitumoral immune response and inhibits visceral metastasis of breast carcinoma |
|
https://doi.org/10.18632/oncotarget.24931
|
| 19147-19158 |
|
| MicroRNA652 induces NED in LNCaP and EMT in PC3 prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.24937
|
| 19159-19176 |
|
| PDL1 expression in medulloblastoma: an evaluation by subgroup |
|
https://doi.org/10.18632/oncotarget.24951
|
| 19177-19191 |
|
| Impact of pigment epitheliumderived factor on colorectal cancer in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.24953
|
| 19192-19202 |
|
| Identification of an EPC2PHF1 fusion transcript in lowgrade endometrial stromal sarcoma |
|
https://doi.org/10.18632/oncotarget.24969
|
| 19203-19208 |
|
| Myoferlin regulates epithelial cancer cell plasticity and migration through autocrine TGFβ1 signaling |
|
https://doi.org/10.18632/oncotarget.24971
|
| 19209-19222 |
|
| Comprehensive genomic transcriptomic tumornormal gene panel analysis for enhanced precision in patients with lung cancer |
|
https://doi.org/10.18632/oncotarget.24973
|
| 19223-19232 |
|
| Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia |
|
https://doi.org/10.18632/oncotarget.24976
|
| 19233-19244 |
|
| Global burden of neuroendocrine tumors and changing incidence in Kentucky |
|
https://doi.org/10.18632/oncotarget.24983
|
| 19245-19254 |
|
| Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology |
|
https://doi.org/10.18632/oncotarget.24995
|
| 19255-19262 |
|
| Recombinant methioninase combined with doxorubicin DOX regresses a DOXresistant synovial sarcoma in a patientderived orthotopic xenograft PDOX mouse model |
|
https://doi.org/10.18632/oncotarget.24996
|
| 19263-19272 |
|
| Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells |
|
https://doi.org/10.18632/oncotarget.25018
|
| 19273-19282 |
|
| Circulating tumor cells tumorderived extracellular vesicles and plasma cytokeratins in castrationresistant prostate cancer patients |
|
https://doi.org/10.18632/oncotarget.25019
|
| 19283-19293 |
|
| Patient derived xenografts PDX predict an effective heparanasebased therapy for lung cancer |
|
https://doi.org/10.18632/oncotarget.25022
|
| 19294-19306 |
|
| Comparison and evaluation of two RGD peptides labelled with 68Ga or 18F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinoma |
|
https://doi.org/10.18632/oncotarget.25028
|
| 19307-19316 |
|
| Treosulfan induces distinctive gonadal toxicity compared with busulfan |
|
https://doi.org/10.18632/oncotarget.25029
|
| 19317-19327 |
|
| Stress and stem cells: adult Muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells |
|
https://doi.org/10.18632/oncotarget.25039
|
| 19328-19341 |
|
| Impact of mutational studies on the diagnosis and the outcome of highrisk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5azacytidine |
|
https://doi.org/10.18632/oncotarget.25046
|
| 19342-19355 |
|
| Circulating and tumorassociated caspase4: a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25049
|
| 19356-19367 |
|
| Radiotherapy increases plasma levels of tumoral cellfree DNA in nonsmall cell lung cancer patients |
|
https://doi.org/10.18632/oncotarget.25053
|
| 19368-19378 |
|
| Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma |
|
https://doi.org/10.18632/oncotarget.25056
|
| 19379-19395 |
|
| Advanced pancreatic cancer: a metaanalysis of clinical trials over thirty years |
|
https://doi.org/10.18632/oncotarget.25036
|
| 19396-19405 |
Clinical Research Papers
|
| Efficacy and safety of sorafenib for advanced renal cell carcinoma: realworld data of patients with renal impairment |
|
https://doi.org/10.18632/oncotarget.24779
|
| 19406-19414 |
Reviews
|
| Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review |
|
https://doi.org/10.18632/oncotarget.24767
|
| 19415-19426 |
|
| Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology |
|
https://doi.org/10.18632/oncotarget.24827
|
| 19427-19442 |
|
| Epigenetic regulation of long noncoding RNAs in gastric cancer |
|
https://doi.org/10.18632/oncotarget.23821
|
| 19443-19458 |
Corrections
|
| Correction: Niclosamide and its analogs are potent inhibitors of Wnt/βcatenin mTOR and STAT3 signaling in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.25151
|
| 19459-19459 |
|
| Correction: Role of novel histone modifications in cancer |
|
https://doi.org/10.18632/oncotarget.25152
|
| 19460-19460 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
